| Chairman |
|
Kang Xinshan |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman & General Manager: Kang Xinshan
Executive Director: Feng Yan, Chen Guangming, Chen Shuyi
Non-executive Director: Xu Dong, Wang Xinkun
Independent Non-executive Director: Gong Weimin, Wang Shan Shan, Pu Meiting.
|
| Principle Business |
|
The Group is principally engaged in the research and development, manufacturing and sale of pharmaceutical products in the PRC. |
| Related Indexes | | Hang Seng Healthcare Industry Index | Hang Seng Composite Index | | Hang Seng Healthcare Index | Hang Seng Composite SmallCap Index |
|
| Major Shareholders |
| Kang Xinshan & ASSO | 27,670,690 | H Sh | 35.16% | 35.16% | 2025/10/20 | | Tu Liandong & ASSO | 16,003,450 | H Sh | 20.33% | 20.33% | 2025/10/20 | | Fujian Province Investment Development Group Co., Ltd. | 7,000,000 | H Sh | 8.89% | 8.89% | 2025/10/20 | | Fuzhou Financial Holding Group Co., Ltd. | 4,680,000 | H Sh | 5.95% | 5.95% | 2025/10/20 |
|
|
|
|
|